Radiologists called for action to reduce the release of contrast media in hospital wastewater after contrast-enhanced examinations in a dedicated session at ECR 2023 last March.
An estimated 300 million CT examinations are being performed each year in the world. This number is expected to grow, and with it, the amount of iodinated contrast media (ICM) used in radiology, according to Professor Olivier Clément, Head of Imaging at Georges Pompidou European Hospital in Paris, and Chair of the contrast media committee of the European Society of Urogenital Radiology (ESUR). “If you assume that 40 percent of CT scans are being carried out with an average of 100 milliliters of contrast media you end up with 12 million liters of ICM that are being injected in patients and then evacuated in the sewage,” he told the audience in Vienna.
This contamination of the aquatic environment is being increasingly studied. In Germany, for example, about 200 kilograms of contrast media are released in the Rhine river every day. “That’s 70.9 tons per year. It’s a lot and it means that we can really recover ICM from the aquatic environment,” he said.
A global issue
There are also review studies about contrast media’s effects on the environment. In a paper published in the Science of the Total Environment in 2021, a team of researchers found that, whatever the contrast media used, a large amount was found not just in hospitals’ sewage wastewater but also in surface, ground and drinking water in North America, Asia and Europe.
“It’s a global problem, a world issue of contamination of surface and drinking water due to contrast media release,” he said.
The contribution of ICM to water pollution can be as high as 80 percent in the mass loading of pharmaceuticals in a hospital’s effluent, because of the amount of ICM that is being injected, he went on. “When we inject antibiotics, we inject up to three grams per patient. But when we inject ICM, we inject up to 45 grams per patient so the mass of contrast media is much higher.”
In themselves ICMs are not dangerous. The threat comes from the disinfection process in the treatment plants, that use chemicals such as chlorine and chloramine. These products create toxic iodinated disinfection byproducts (IDBPS) that can be found in the aquatic environment and drinking water. “This is really the environmental problem of using contrast media,” he said.
Radiologists should be aware of the issue and work to decrease pollution linked with ICM use. “First we should inject less contrast media and respect the indication, i.e. always inject dose which is related to weight, especially for oncologic imaging,” he suggested. “We should reduce waste and use the adequate vial for the patient, i.e. open a vial of 100 milliliters when we use 90 and not a vial of 150. We should also recycle the residue in the vial.”
Taking steps is also important because of the high demand for ICM all over the world. “Vendors can produce a certain amount of ICM per year that isn’t even sufficient for all the examinations,” he said. “So we must think of how we use these products and find new ways to inject less contrast, with low kV and AI for example.”
Although different software are being trained to reduce ICM dose, a small amount of contrast media remains necessary to create contrast in the image, he believes. “We will still need contrast media in radiology for a long time.”
Strategies to reduce pollution include releasing ICM in hospital
circuits linked with specific plants, installing dry toilets for patients who have undergone a contrast-enhanced examination, and collecting urine in bags to be incinerated, since incineration is less polluting than using ICBPs to purify the water.
“The radiology community should be aware of the huge amount of iodine contrast media released in the environment,” he concluded. “We should inject wisely, know about toxic IDBPs in plants and take specific measures to decrease the effluence.”
The Greenwater project
Iodine contrast media are not the only source of concern when it comes to residuals in hospital wastewater. About 50 million of gadolinium-based contrast agents (GBCA) doses are being injected per year and then evacuated in the sewage, according to Professor Franceso Sardanelli, Director of the Department of Radiology at the Research Hospital (IRCCS) Policlinico San Donato in Milan, where the Greenwater study was recently launched.
The project aims to evaluate the extent of retrievable ICM and GBCA from the urine collected after CT and MRI scans, and to assess patient acceptance to participate in the study – the ‘green sensitivity’.
The study was carried out with urine collection within 60 minutes of administering the contrast agent, so about 30 minutes after the examination. Results have been both surprising and encouraging, Sardanelli explained.
“The first unexpected finding to me was the high acceptance from patients,” he said. “94 percent of them agreed to take part in the study and stay half an hour more in the department. That means that we can go in this direction quite effortlessly.”
The fact that patients wanted to cooperate in the project is very good news for manufacturers and hospitals, he added. “It shows patients are highly sensitive to sustainability. Even in a hectic city like Milan, people took the time. We have to use this availability.”
The future will be to recycle both iodine and gadolinium agents, by creating virtuous cycles in which the product comes back to the producer after it has been injected in the patient. “That would make sense,” he concluded. “Recycling is the solution.”
This article was first published in European Hospital · www.healthcare-in-europe.com
